AI Generated Image
GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
ABC News - Breaking News, Latest News and Videos • • health
Key Points:
- A study published in JAMA Psychiatry found that 32% of patients with eating disorders have used GLP-1 weight loss injections, more than double the 15% usage rate in the general population.
- Over 10% of participants with eating disorders misused GLP-1 drugs by altering doses, extending use beyond prescriptions, tampering with injection equipment, or sharing the medication.
- Experts warn that GLP-1 drugs, while beneficial for conditions like type 2 diabetes and obesity, can exacerbate eating disorders by encouraging harmful eating restrictions and complicating nutritional health.
- Medical professionals suggest routine screening for eating disorders before prescribing GLP-1s to ensure closer monitoring of at-risk patients as these drugs become more widely accessible.
- Rapid weight loss from GLP-1 use may mask the re-emergence of eating disorders, highlighting the importance of seeking support and professional help for recovery.
![Apple Store is down: 'We’re making updates,' Apple says [Update: Back online]](https://media-cdn.cashwalklabs.io/https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fimages.cashwalklabs.io%2F0_admin%2Fnews-ai-images%2F019eff50-b84d-74e8-b323-fd285ceebf72.webp?format=webp&w=120&h=80)
